![Eli Grong Aursand](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eli Grong Aursand
Director/Miembro de la Junta en Nadeno Nanoscience AS .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Annbjørg Falck | F | - |
Nadeno Nanoscience AS
![]() Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | - |
Nils Spidsøe | M | 73 |
Sintef TTO AS
![]() Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | 20 años |
Yrr Mørch | F | - |
Nadeno Nanoscience AS
![]() Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | - |
Anders Lian | M | 64 |
Sintef TTO AS
![]() Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | 20 años |
Jostein Steensnaes Bjøndal | M | 59 |
Sintef TTO AS
![]() Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | 22 años |
Ole Dahlberg | M | - |
Nadeno Nanoscience AS
![]() Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | - |
John Tarje Torvik | M | - |
Sintef TTO AS
![]() Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | 10 años |
Inge Hovd Gangås | M | - |
Sintef TTO AS
![]() Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | 8 años |
Reidar Olaf Stokke | M | 67 |
Nadeno Nanoscience AS
![]() Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | - |
Morten Frost-Nielsen | M | - |
Sintef TTO AS
![]() Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | 8 años |
Duncan Akporiaye | M | - |
Sintef TTO AS
![]() Sintef TTO AS Investment ManagersFinance Sintef TTO AS is a venture capital firm located in Trondheim, Norway. Sintef TTO is a wholly-owned subsidiary of SINTEF, established in 1950, one of the largest independent research organizations in the Nordic region. Their areas of research encompass information and communications technology, technology management, marine activities, materials science and applied chemistry, health, petroleum, energy, and construction. Sintef TTO, as the group's development firm, is responsible for their innovation activities. They are also the owner and manager of SINTEF's Intellectual Property Rights (IPR). They are the investment manager of several funds, namely SINTEF Venture III AS, Sinvent Venture, and SpinOutVenture II AS. | - |
Jonas Hallén | M | - |
Nadeno Nanoscience AS
![]() Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | - |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
País | Relaciones | % del total |
---|---|---|
Noruega | 12 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Eli Grong Aursand
- Red Personal